American International Group’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-58,847
Closed -$1.21M 765
2024
Q1
$1.21M Buy
58,847
+122
+0.2% +$2.5K ﹤0.01% 1206
2023
Q4
$1.26M Sell
58,725
-237
-0.4% -$5.09K 0.01% 1186
2023
Q3
$1.22M Buy
58,962
+2,096
+4% +$43.2K 0.01% 1147
2023
Q2
$1.68M Buy
56,866
+4,336
+8% +$128K 0.01% 1018
2023
Q1
$1.21M Buy
52,530
+1,046
+2% +$24.1K 0.01% 1145
2022
Q4
$1.43M Buy
51,484
+4,707
+10% +$131K 0.01% 1049
2022
Q3
$1.44M Buy
46,777
+661
+1% +$20.3K 0.01% 1037
2022
Q2
$1.36M Buy
46,116
+945
+2% +$27.8K 0.01% 1077
2022
Q1
$1.45M Sell
45,171
-3,179
-7% -$102K 0.01% 1143
2021
Q4
$2.16M Sell
48,350
-1,447
-3% -$64.5K 0.01% 1044
2021
Q3
$2.51M Sell
49,797
-1,183
-2% -$59.7K 0.01% 965
2021
Q2
$4K Buy
50,980
+12,457
+32% +$977 0.01% 897
2021
Q1
$2.2K Sell
38,523
-151
-0.4% -$9 0.01% 1072
2020
Q4
$3.24K Buy
38,674
+1,071
+3% +$90 0.01% 920
2020
Q3
$1.35M Sell
37,603
-856
-2% -$30.7K 0.01% 1111
2020
Q2
$930K Buy
38,459
+7,594
+25% +$184K ﹤0.01% 1263
2020
Q1
$540K Buy
30,865
+840
+3% +$14.7K ﹤0.01% 1385
2019
Q4
$523K Sell
30,025
-252
-0.8% -$4.39K ﹤0.01% 1668
2019
Q3
$464K Sell
30,277
-211
-0.7% -$3.23K ﹤0.01% 1705
2019
Q2
$633K Buy
30,488
+1,430
+5% +$29.7K ﹤0.01% 1570
2019
Q1
$675K Sell
29,058
-942
-3% -$21.9K ﹤0.01% 1543
2018
Q4
$620K Sell
30,000
-231
-0.8% -$4.77K ﹤0.01% 1547
2018
Q3
$657K Buy
30,231
+19,217
+174% +$418K ﹤0.01% 1711
2018
Q2
$168K Buy
11,014
+697
+7% +$10.6K ﹤0.01% 2465
2018
Q1
$203K Buy
+10,317
New +$203K ﹤0.01% 2253